Varicella-zoster virus vaccine: Molecular genetics

Current Topics in Microbiology and Immunology

Volumn 342, Issue 1, 2010, Pages 323-340

  Schmid, D Scott ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE; HERPES VACCINE; VIRUS DNA;

ARTICLE; CHICKENPOX; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; GENETIC CONSERVATION; GENETIC MARKER; GENETIC RECOMBINATION; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VIRUS STRAIN; WILD TYPE; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; IMMUNOLOGY; REVIEW; VARICELLA ZOSTER VIRUS; VIROLOGY;

HUMAN HERPESVIRUS 3;

AMINO ACID SEQUENCE; CHICKENPOX; DNA, VIRAL; GENETIC MARKERS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HERPESVIRUS VACCINES; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 79952045303     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-14     Document Type: Article

References (71)

1. Argaw T, Cohen JI, Klutch M, Lekstrum K, Yoshikawa T, Asano Y, Krause PR (2000) Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J Infect Dis 181:1153-1157 (Pubitemid 30194506)
2. Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudry QL, Siquera M, Poulsen A, Yamanishi K, Breuer J (2003) Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol 70(Suppl 1):S42-S47 (Pubitemid 36368844)
3. Breuer J, Schmid DS (2008) Vaccine Oka variants and sequence variability in vaccine-related skin lesions. J Infect Dis 197(Suppl 2):S54-S57 (Pubitemid 351590146)
4. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G (2000) Modeling the impact of immunization on the epidemiology of varicella-zoster virus. Epidemiol Infect 125:651-669 (Pubitemid 32156853)
5. CDC (1996) Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45 (RR-11)
6. CDC 1999a) Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). M.M.W.R. Recomm. Rep 48 (No. RR-6)
7. CDC (1999b) Outbreak of varicella among vaccinated children -Michigan, 2003. MMWR 53:389-392
8. Cohrs RJ, Gilden DH, Gomi Y, Yamanishi K, Cohen JI (2006) Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-zoster virus. J Virol 80:2076-2082 (Pubitemid 43271514)
9. Faga KI, Maury W, Bruckner DA, Grose C (2001) Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology 280:355-363
10. Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT (1994) Age specific incidence of chickenpox. Public Health Rep 109:750-755
11. Gomi Y, Imagawa T, Takahashi M, Yamanishi K (2000) Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J Med Virol 61:497-503 (Pubitemid 30450692)
12. Gomi Y, Imagawa T, Takahashi M, Yamanishi K (2001) Comparison of DNA sequence and transactivation of open reading frame 62 of Oka varicella vaccine and its parental viruses. Arch Virol (Suppl 17):49-56 (Pubitemid 33760017)
13. Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K (2002) Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76:11447-11459 (Pubitemid 35231301)
14. Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF (2008) Changing varicella epidemiology in active surveillance sites -United States, 1995-2000. J Infect Dis 197(Suppl 2):S71-S75 (Pubitemid 351590150)
15. Haberland M, Meyer-König U, Hufert FT (1999) Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol 80:1495-1500 (Pubitemid 29261481)
16. Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Strauss SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM, Shingles Prevention Study Group (2009) A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol 81:1310-1322
17. Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC) (2008) Prevention of herpes zoster: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 57(RR-5):1-30
18. Hawrami K, Breuer J (1997) Analysis of United Kingdom wild type strains of varicella-zoster virus: differentiation from the Oka vaccine strain. J Med Virol 53:60-62 (Pubitemid 27395896)
19. Hawrami K, Hart LJ, Pereira F, Argent S, Bannister B, Bovill B, Carrington D, Ogilvie M, Rawstorne S, Tryhorn Y, Breuer J (1997) Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995. J Clin Microbiol 35:2807-2809 (Pubitemid 27452414)
20. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M (1984) Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J Infect Dis 149:956-963 (Pubitemid 14082160)
21. Hayakawa Y, Yamamoto T, Yamanishi K, Takahashi M (1986) Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI. J Gen Virol 67:1817-1829 (Pubitemid 16017267)
22. Hondo R, Yogo Y, Yoshida M, Fujima A, Itoh S (1989) Distribution of varicella-zoster virus strains carrying a Pst-site-less mutation in Japan and DNA change responsible for the mutation. Jpn J Exp Med 59:233-237 (Pubitemid 20123967)
23. Kemble GW, Annunziato P, Lungu O, Winter RE, Cha T-A, Silverstein SJ, Spaete RR (2000) Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J Virol 74:11311-11321 (Pubitemid 32224001)
24. Koskiniemi M, Lappalainen M, Schmid DS, Rubtcova E, Loparev VN (2007) Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland. Clin Vaccine Immunol 14:1057-1061 (Pubitemid 47518070)
25. Koshizuka T, Yamanishi K, Mori Y (2009) Comparison and characterization of VZV encoded ORF0 of the parental and vaccine strains. 34th International Herpesvirus Workshop, Abstract 1.70
26. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S (1992) Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild type varicella-zoster virus isolates. J Virol 66:1016-1020
27. La Russa P, Steinberg S, Arvin A, Dwyer D, Burgess M, Menegus M, Rekrut K, Yamanishi K, Gershon A (1998) Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis 178(Suppl 1):S64-S66 (Pubitemid 28514273)
28. Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS (2000a) Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol 38:3156-3160
29. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS (2000b) Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 38:4315-4319 (Pubitemid 32244512)
30. Loparev VN, Gonzalez A, Deleon-Carnes M, Tipple G, Fickenscher H, Torfason EG, Schmid DS (2004) Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 78:8349-8358 (Pubitemid 38944319)
31. LoparevV,MartroE,RubtcovaE,Rodrigo C, Piette JC,CaumesE,Vernant JP, SchmidDS, FilletAM (2006) Toward universal varicella-zoster virus genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol 45:559-563
32. Loparev VN, Rubtcova EN, Bostik V, Govil D, Birch CJ, Druce JD, Schmid DS, Croxson MC (2007a) Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand. J Virol 81:12758-12765 (Pubitemid 350156913)
33. Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS (2007b) DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis 195:502-510 (Pubitemid 46214392)
34. Loparev VN, Rubtcova EN, Bostik V, Tzaneva V, Sauerbrei A, Robo A, Sattler-Dornbacher E, Hanovcova I, Stepanova V, Splino M, Eremin V, Koskiniemi M, Vankova OE, Schmid DS (2009) Distribution of varicella-zoster virus (VZV) wild type genotypes in northern and Southern Europe: evidence for high conservation of circulating genotypes. Virology 383:216-225
35. Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL (2006) One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 117:e1070-e1077 (Pubitemid 46074632)
36. Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS (2008) Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 197:646-653 (Pubitemid 351364461)
37. Marin M, Guris D, Chaves SS, Schmid S, Seward JF (2007) Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recom Rep 56 (RR-4):1-37
38. McGeoch D (2009) Lineages of varicella-zoster virus. J Gen Virol 90:963-969
39. Midgley RS, Blake NW, Yao QY, Croom-Carter D, Cheung ST, Leung SF, Chan ATC, Johnson PJ, Huang D, Rickenson AB, Lee SP (2000) Novel intertypic recombinants of Epstein Barr virus in the Chinese population. J Virol 74:1544-1548 (Pubitemid 30044106)
40. Mori C, Takahara R, Toriyama T, Nagai T, Takahashi M, Yamanishi K (1998) Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J Infect Dis 178:35-38 (Pubitemid 28328073)
41. Muir WB, Nichols R, Breuer J (2002) Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol 76:1971-1979 (Pubitemid 34094643)
42. Neve B, Froguel P, Corset L, Valliant E, Vatin V, Boutin P (2002) Rapid SNP allele frequency determination in genomic DNA pools by pyrosequencing. Biotechniques 32:1138-1142 (Pubitemid 34492392)
43. Norberg P, Kasubi MJ, Haarr L, Bergström T, Liljeqvist JA (2007) Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol 81:13158-13167 (Pubitemid 350161623)
44. Norberg P, Liljeqvist J-Å, Bergström T, Sammons S, Schmid DS, Loparev VN (2006) Completegenome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol 80:9569-9576 (Pubitemid 44444660)
45. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS (2005) Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J Mol Diagn 7:413-421 (Pubitemid 41149657)
46. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Jr. Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL, Shingles Prevention Study Group (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271-2284
47. Parker SP, Quinlivan M, Taha Y, Breuer J (2006) Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J ClinMicrobiol 44:3911-3914 (Pubitemid 44737227)
48. Peters GA, Tyler SD, Grose C, Severini A, Gray MJ, Upton C, Tipples GA (2006) A full genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol 80:9850-9860 (Pubitemid 44435659)
49. Poole LJ, Zong J-C, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, Orenstein JM, Reitz MS, Hayward GS (1999) Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 73:6646-6660 (Pubitemid 29327847)
50. Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulson A, Siqueira M, Takahashi M, Talukder Y, Yamanishi K, Leedham-Cross M, Scott FT, Thomas SL, Breuer J (2002) The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis 186:888-894
51. Quinlivan ML, Gershon AA, Steinberg SP, Breuer J (2004) Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J Infect Dis 190:793-796 (Pubitemid 39050010)
52. Quinlivan MA, Gershon AA, Nichols RA, LaRussa P, Steinberg SP, Breuer J (2006) Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions. J Infect Dis 193:927-930
53. Sauerbrei A, Wutzler P (2007) Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. J Med Virol 79:1025-1031 (Pubitemid 46871563)
54. Sauerbrei A, Rubtcova E, Wutzler P, Schmid DS, Loparev VN (2004) Genetic profile of an Oka vaccine variant isolated from an infant with zoster. J Clin Microbiol 42:5604-5608 (Pubitemid 39664343)
55. Sauerbrei A, Zell R, Wutzler P (2007) Analysis of the repeat units in the R2 among different Oka varicella-zoster virus vaccine strains and wild type strains in Germany. Intervirology 50:40-44 (Pubitemid 46005270)
56. Schmid DS, V Bostik, J Folster, N Jensen, P Norberg, B Bankamp, K Hummel (2008) 33rd international herpesvirus workshop. Evidence for recombination between Oka vaccine and wild type strains among clinical varicella-zoster virus (VZV) isolates. Abstr 803
57. Schmidt-Chanasit J, Olschläger S,Günther S, JaegerG, BleymehlK, Schäd SG,Heckel G, Ulrich RG, Doerr HW (2008) Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype Clade 5. J Clin Microbiol 46:3540-3543
58. Sengupta N, Taha Y, Scott FT, Leedham-Green ME, Quinlivan M, Breuer J (2007) Varicella zoster genotypes in East London: a prospective study in patients with herpes zoster. J Infect Dis 196:1014-1020 (Pubitemid 47580295)
59. Sergeev N, Rubtcova E, Chizikov V, Schmid DS, Loparev VN (2006) New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods 136:8-16 (Pubitemid 44069586)
60. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, Jumaan AO, WhartonM(2002) Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287:606-611 (Pubitemid 34252012)
61. Shiraki K, Horiuchi K, Asano Y, Yamanishi K, Takahashi M (1991) Differentia-tion of Oka varicella vaccine strain from wild varicella zoster virus strains isolated from vaccinees and household contact. J Med Virol 33:128-132
62. Silvertsson Å, Plantz A, Hansson J, Lundeberg J (2002) Pyrosequencing as an alternative to single strand conformation polymorphism analysis for detection of N-ras mutations in human melanoma metastases. Clin Chem 48:2164-2170 (Pubitemid 35397558)
63. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288-1290
64. Tipples GA, Safronetz D, Gray M (2003) A real-time PCR assay for the detection of varicellazoster virus DNA and differentiation of vaccine, wild-type and control strains. J Virol Methods 113:113-116 (Pubitemid 37205127)
65. Toi CS, Dwyer DE (2008) Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms. J Clin Virol 43:18-24
66. Umene K, Oohashi S, Yoshida M, Fukumaki Y (2008) Diversity of the a sequence of herpes simplex virus type 1 developed during evolution. J Gen Virol 89:841-852
67. Wagenaar T, Chow VTK, Buranathai C, Thawasupha P, Grose C (2003) The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072-1081 (Pubitemid 36139937)
68. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N (1994) The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J Virol 68:7918-7926 (Pubitemid 24362679)
69. Wharton M (1996) The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 10:571-581 (Pubitemid 26285287)
70. Yawn BP, Yawn RA, Lydick E (2003) Community impact of childhood varicella infections. J Pediatr 130:759-765
71. Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H (2007) Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol 81:9024-9033 (Pubitemid 47311446)